StockTipsArenaBeta

BUY Dr. Reddy's Laboratories Limited — Swati Hotkar, Nirmal Bang Securities

BUYDr. Reddy's Laboratories Limited
Dr. Reddy's Laboratories share price target & all analyst calls

bySwati Hotkar, Nirmal Bang SecuritiesHorizon: NA (inferred Intraday)10 Aug 2026, 1:42 pm ISTvia CNBC Awaaz.

Entry₹1,167Inferred
Target₹1,200
Total upside +2.83% (call closed)
Stop loss₹1,150-1.46% risk
At expiry₹1,160.410 Aug 2026, 3:05 pm
Expired-0.57%
Follow Swati Hotkar for new calls(0% target hit, 11 closed calls)Get alertsWatch DRREDDY for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 10 Aug 2026
1 supporting1 neutral0 opposing
Supports the BUY call (1)

1 advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·4 Aug · 6d ago

Neutral / worth noting (1)

Dr Reddy's ends distribution deal with Novartis India after ownership change

NewsCnbc-Tv18·7 Aug · 2d ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Dr. Reddy's Laboratories

All analyst calls on Dr. Reddy's Laboratories

More from Swati Hotkar, Nirmal Bang Securities

Every call and its outcome